Your session is about to expire
← Back to Search
MED-Go App for Sickle Cell Disease
Study Summary
This trial will test a new app to help people with sickle cell disease take their medication as prescribed. The goal is to improve health outcomes for these patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 12 and 21 years old.I have been taking hydroxyurea consistently for 2 months.I have a type of sickle cell disease.
- Group 1: Control Arm
- Group 2: MED-Go app Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria makes a person qualified to take part in this clinical trial?
"For this investigation, 40 children aged 12 to 21 with anemia and sickle cell must be recruited. In addition, all participants should possess or have access to a smartphone over the period of the trial."
Is the age range for participation in this experiment extending beyond 30 years?
"Adhering to the trial's regulations, individuals aged 12-21 may be enrolled as participants."
Are there currently opportunities for participants in this experiment?
"As per clinicaltrials.gov records, this medical research is still in the process of recruiting volunteers. The trial was initiated on September 28th 2020 with recent modifications made to it on March 7th 2022."
What is the upper limit of enrollees for this clinical trial?
"Affirmative. According to clinicaltrials.gov, this experiment began recruiting on September 28th 2020 and recently amended its information on March 7th 2022. This trial requires 40 individuals from a single medical facility for participation."
Share this study with friends
Copy Link
Messenger